Search research articles
Contact Us
Filters
Showing results (181-190 of 198) with videos related to
Page
of 20
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 15, 2000
Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues
Z Ye, Y Gao, R K Bakshi, et al.
Molecular Psychiatry
|
December 16, 2004
Tree pollen peaks are associated with increased nonviolent suicide in women
T T Postolache, J W Stiller, R Herrell, et al.
Science (New York, N.Y.)
|
October 23, 1998
Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry
S P Rohrer, E T Birzin, R T Mosley, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
August 23, 2012
Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)
A Sharma, S Apostolidou, M Burnell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 1998
Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2
L Yang, S C Berk, S P Rohrer, et al.
British Journal of Cancer
|
April 19, 2014
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
T S Maughan, A M Meade, R A Adams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
B Basu, M G Krebs, R Sundar, et al.
BMJ Global Health
|
October 27, 2018
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India
Patrick K Moonan, Sreenivas A Nair, Reshu Agarwal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2005
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration
G Stuart, E Avall-Lundqvist, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2005
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
A du Bois, M Quinn, T Thigpen, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 198) with videos related to
Sort By:
Page
of 20
Bioorganic & Medicinal Chemistry Letters
|
January 15, 2000
Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues
Z Ye, Y Gao, R K Bakshi, et al.
Molecular Psychiatry
|
December 16, 2004
Tree pollen peaks are associated with increased nonviolent suicide in women
T T Postolache, J W Stiller, R Herrell, et al.
Science (New York, N.Y.)
|
October 23, 1998
Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry
S P Rohrer, E T Birzin, R T Mosley, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
August 23, 2012
Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)
A Sharma, S Apostolidou, M Burnell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 1998
Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2
L Yang, S C Berk, S P Rohrer, et al.
British Journal of Cancer
|
April 19, 2014
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
T S Maughan, A M Meade, R A Adams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
B Basu, M G Krebs, R Sundar, et al.
BMJ Global Health
|
October 27, 2018
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India
Patrick K Moonan, Sreenivas A Nair, Reshu Agarwal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2005
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration
G Stuart, E Avall-Lundqvist, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2005
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
A du Bois, M Quinn, T Thigpen, et al.
Page
of 20